Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Delhi High Court Rules In Favour Of Reddy's Laboratories On Use Of The Mark RAZOFAST By Fast Cure Pharma

    In the recent case of Dr. Reddy's Laboratories Ltd vs Fast Cure Pharma, the plaintiff applied to the Delhi High Court for a permanent injunction restraining the defendant from manufacturing...
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    EMA Publishes New Guidelines For Certain Medical Devices

    On February 28, 2019, European Medicine Agency published the first guidance on new rules for certain medical devices - the first of a series of guidance documents to help applicants to prepare for compliance with these new rules.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
S&A Law Offices
  • Article

    Virchow Group Partners With Germany-Based Symrise Group

    JSA assisted the Virchow Group, a world leader in several pharmaceutical actives, in relation to establishing its strategic joint venture arrangement with the Germany-based Symrise Group...
    GlobalFood, Drugs, Healthcare, Life Sciences
    JSA Advocates & Solicitors
    JSA Advocates & Solicitors
  • Article

    Food & Pharma Flash - July 2014

    The National Pharmaceutical Pricing Authority issued guidelines for stoppage of scheduled formulations under paragraph 21(2) of Drug Pricing Control Order, 2013.
    IndiaFood, Drugs, Healthcare, Life Sciences
    PSA
    PSA
  • Article

    Indian Molecular Assay TrueNat To Be Included In WHO Global TB Programme

    On January 16, 2020, Indian Council of Medical Research announced a significant development that the WHO Global TB Programme has included an Indian Molecular assay...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Public Health At A Crossroads: Legal And Regulatory Dimensions Of The Proposed Drugs Rules Amendment, 2026

    On 9th March 2026, the Ministry of Health and Family Welfare, Government of India, published a significant draft amendment to the Drugs Rules, 1945, by way of Gazette Notification G.S.R. 164(E).
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Regulatory Action By CDSCO On Drug Adverse Events: A Year-end Review

    The Central Drugs Standard Control Organization (CDSCO), New Delhi, under the aegis of the Ministry of Health ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Contemplating Compulsory Licensing: A Comparison Between The Components

    Compulsory licensing is the "buzz-word" doing the rounds of the Indian Pharma Industry. With the first compulsory license application for anti-cancer drugs being underway, the law governing the regime finds itself under the speculative eye.
    IndiaImmigration
    Lex Orbis
    Lex Orbis
  • Article

    Generics And Innovators - Saying I Do And Doing Battle

    Arguably, the opening of the Indian economy and India's Patents (Amendment) Act 2005 has had a most significant impact in the area of pharmaceuticals. With the new regime, the $8 billion Indian pharmaceutical industry has been forced to adapt and recast its business models.
    IndiaIntellectual Property
    Spruson & Ferguson Lawyers
    Spruson & Ferguson Lawyers
  • Article

    Global Intellectual Property Index: India's Ranks 44 Out Of 50

    In the 2018 Global Intellectual Property Index, India has secured 44th position out of 50 countries - a jump from 43rd of 45 economies in 2017.
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Medical Equipment And Device Manufacturers Company Hollister Won A $9 Million Patent Fraud Suit Against Zassi Holdings Inc.

    Medical Equipment And Device Manufacturers Company Hollister Inc. won a fraud suit against Zassi Holding Inc. which was for $9.2 million.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Monsanto Vs Nuziveedu Seeds: The BT Cotton Judgment

    Monsanto Company is an agrochemical and agricultural biotechnology corporation acquired by Bayer Corporation that conducts research on genetically modified seeds and agricultural crops.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Scan Biotech India & Another Successful In Establishing Infringement Of Its Trademark As Well As Infringement In Terms Of Section 29 (5), Trademark Act, 1999.

    In Scan Biotech India & Another v Scan Biotech India , Scan Biotech India & Another (Plaintiffs), a pharmaceutical product manufacturing concern sought permanent injunction against Scan Biotech India (Defendant) for their use of the trademark "BOLRAN" and the use of the trade name "SCAN BIOTEK INDIA".
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Three-Days Symposium On Pharmaceutical, Biotechnology & Chemical Patent Laws

    IIPRD has been successfully conducting several symposiums over the years on different Intellectual Property (IP) aspects.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Need For Improving Pharmaceutical Laws - The Proposed Way Forward

    With the rising need to accommodate the new requirements and adaptation of modern technology in the pharmaceutical sector, the draft of the ‘Drugs, Medical Devices and Cosmetics Bill, 2022'...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Dentons
    Dentons
  • Article

    New Drug Approval: Regulatory Scenario In India

    Considering the Indian pharmaceutical industry is the third largest industry in terms of output, it is necessary to understand the regulatory scenario for the pharma sector...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Lex Orbis
    Lex Orbis
  • Article

    India Moves On ……

    A generic manufacturer spends virtually nothing on R&D, does not mean that without effort generics can be marketed. It actually requires the demonstration of safety and effect of the product by the innovator to the regulator for approval.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Sitagliptin Judgement: An Overview

    In a recent, very intensely contested litigation between Merck Sharp and Glenmark Pharmaceuticals Ltd., the Hon'ble Delhi High Court delivered a much awaited judgement. In the suit Merck contended infringement of its Anti-diabetic drug Sitagliptin ..
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    European Commission Approval To Rituximab Is First Biologic Treatment For A Rare Autoimmune Disease

    These cells are central to many blood cancers, including common forms of lymphoma and leukaemia.
    European UnionFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Alteration To The Definition Of A Startup - A Relief For The Biotech Sector

    In reference to the biotechnology sector including medical device, the period shall be up to ten years from the date of its incorporation/ registration.
    IndiaCorporate/Commercial Law
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Showing 41–60 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics